Jeffrey Jaime, CISSPServant Leader & CEO Driving AI Innovation and Team Excellence

Peptides: Affordable Solutions for Optimal Health

11 Jul 2023 · 1 min

Watch on YouTube

0:52

A speaker (Jeffrey Jaime, CISSP) argues that peptide therapies have widespread applications and should be affordable and accessible beyond wealthy clients. He recounts frustration with doctors overcharging for peptide regimens and describes founding a peptide company with colleagues to charge only a moderate profit over compounding costs, aiming to serve a large number of people (target contrasted as servicing ~200,000 people rather than 2,000 wealthy clients).

Questions this video answers

July 11, 2023

Serve 200,000 people instead of 2,000 rich people.

Chapters

And there's a peptide for almost every application no matter what you're trying to achieve. And so what was frustrating to me is that a lot of doctors were overcharging for peptide regimens and getting people on peptides. And I don't think the peptides should just be for the 1 or 1% of the wealthy or the 5% of society. I think they should be for everyone because they really will help human beings and mankind. And so me and a couple of my buddies that are very, very successful and they're also my age are like hey, let's just start a peptide company where we don't really charge that much. We charge like a, you know, a moderate amount of profit over the cost from the compounding pharmacy or the compounding manufacturer and we will.
We'Ll make this accessible to everyone. We'll make this like let's, let's serve, let's not service 2, 000 rich people. Let's try to service 200, 000 people so that we, we service a lot more people and just not make as.